Multidisciplinary management of malignant pleural effusion

Journal of Surgical Oncology

Volumn 105, Issue 7, 2012, Pages 731-738

  Kaifi, Jussuf T ^a   Toth, Jennifer W ^a   Gusani, Niraj J ^a   Kimchi, Eric T ^a   Staveley O'Carroll, Kevin F ^a   Belani, Chandra P ^a   Reed, Michael F ^b  

^a PENN STATE CANCER INSTITUTE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

chest tube; indwelling pleural catheter; malignant pleural effusion; pleurodesis; thoracentesis; VATS

Indexed keywords

BETA INTERFERON; BLEOMYCIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; DOXORUBICIN; DOXYCYCLINE; INTERLEUKIN 2; MESOTHELIN; MINOCYCLINE; MITOMYCIN; TALC;

BLEEDING; BONE MARROW SUPPRESSION; CELLULITIS; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DECORTICATION; DYSPNEA; EMPYEMA; FEVER; HUMAN; INDWELLING CATHETER; LIFE EXPECTANCY; LUNG EDEMA; LUNG EMBOLISM; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATHOGENESIS; PLEURA EFFUSION; PLEURA FLUID; PLEURECTOMY; PLEURODESIS; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; SEPSIS; SHOCK; SUBCUTANEOUS EMPHYSEMA; SYSTEMATIC REVIEW; THORACOCENTESIS; THORACOSCOPY; THORAX PAIN; THORAX RADIOGRAPHY; TUBE; TUMOR SEEDING; VIDEO ASSISTED THORACOSCOPIC SURGERY;

COMBINED MODALITY THERAPY; HUMANS; PLEURAL EFFUSION, MALIGNANT; SCLEROSING SOLUTIONS; THORACIC SURGERY, VIDEO-ASSISTED; THORACOSCOPY;

EID: 84859897517     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22100     Document Type: Review

References (105)

1. Bielsa S, Martin-Juan J, Porcel JM, et al.: Diagnostic and prognostic implications of pleural adhesions in malignant effusions. J Thorac Oncol 2008; 3: 1251-1256.
2. Awasthi A, Gupta N, Srinivasan R, et al.: Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India. Cytopathology 2007; 18: 28-32. (Pubitemid 46155241)
3. Lee YC, Yasay JR, Johnson JE, et al.: Comparing transforming growth factor-beta2, talc and bleomycin as pleurodesing agents in sheep. Respirology 2002; 7: 209-216.
4. Johnston WW,: The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985; 56: 905-909. (Pubitemid 15228290)
5. Sahn SA,: Malignant pleural effusions. Clin Chest Med 1985; 6: 113-125. (Pubitemid 15049585)
6. Sahn SA,: Pleural diseases related to metastatic malignancies. Eur Respir J 1997; 10: 1907-1913. (Pubitemid 27368388)
7. Aleman C, Alegre J, Segura RM, et al.: Polymorphonuclear elastase in the early diagnosis of complicated pyogenic pleural effusions. Respiration 2003; 70: 462-467. (Pubitemid 37524109)
8. DeCamp MM, Jr. , Mentzer SJ, Swanson SJ, et al.: Malignant effusive disease of the pleura and pericardium. Chest 1997; 112: 291S-295S. (Pubitemid 27441098)
9. Putnam JB, Jr. , Walsh GL, Swisher SG, et al.: Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000; 69: 369-375. (Pubitemid 30125561)
10. Rodriguez-Panadero F, Janssen JP, Astoul P,: Thoracoscopy: General overview and place in the diagnosis and management of pleural effusion. Eur Respir J 2006; 28: 409-422.
11. Guyatt G, Gutterman D, Baumann MH, et al.: Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. Chest 2006; 129: 174-181. (Pubitemid 43265259)
12. Kaifi JT, Gusani NJ, Deshaies I, et al.: Indications and approach to surgical resection of lung metastases. J Surg Oncol 102: 187-195.
13. Turner DJ, Miskulin J,: Management of adrenal lesions. Curr Opin Oncol 2009; 21: 34-40.
14. Light RW, Hamm H,: Malignant pleural effusion: Would the real cause please stand up? Eur Respir J 1997; 10: 1701-1702. (Pubitemid 27368358)
15. - channels in human pleural mesothelioma cells. FEBS Lett 2004; 559: 45-50. (Pubitemid 38186701)
16. Martinez-Moragon E, Aparicio J, Sanchis J, et al.: Malignant pleural effusion: Prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration 1998; 65: 108-113. (Pubitemid 28154293)
17. Chernow B, Sahn SA,: Carcinomatous involvement of the pleura: An analysis of 96 patients. Am J Med 1977; 63: 695-702. (Pubitemid 8222934)
18. Woodring JH,: Recognition of pleural effusion on supine radiographs: How much fluid is required? AJR Am J Roentgenol 1984; 142: 59-64. (Pubitemid 14218808)
19. Heffner JE, Klein JS, Hampson C,: Diagnostic utility and clinical application of imaging for pleural space infections. Chest 2010; 137: 467-479.
20. Patz EF, Jr. , Shaffer K, Piwnica-Worms DR, et al.: Malignant pleural mesothelioma: Value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 1992; 159: 961-966.
21. Sahn SA,: Management of malignant pleural effusions. Monaldi Arch Chest Dis 2001; 56: 394-399. (Pubitemid 34134118)
22. Davies HE, Sadler RS, Bielsa S, et al.: Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 2009; 180: 437-444.
23. Liang QL, Shi HZ, Qin XJ, et al.: Diagnostic accuracy of tumour markers for malignant pleural effusion: A meta-analysis. Thorax 2008; 63: 35-41.
24. Johnston WW, Szpak CA, Lottich SC, et al.: Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions. Cancer Res 1985; 45: 1894-1900. (Pubitemid 15079157)
25. Khaleeq G, Musani AI,: Emerging paradigms in the management of malignant pleural effusions. Respir Med 2008; 102: 939-948.
26. Saffran L, Ost DE, Fein AM, et al.: Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest 2000; 118: 417-421. (Pubitemid 30637809)
27. Livingston RB, McCracken JD, Trauth CJ, et al.: Isolated pleural effusion in small cell lung carcinoma: Favorable prognosis. A review of the Southwest Oncology Group experience. Chest 1982; 81: 208-211. (Pubitemid 12143672)
28. Fujita A, Takabatake H, Tagaki S, et al.: Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer: Cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support. Chest 2001; 119: 340-343. (Pubitemid 32163741)
29. Bruneau R, Rubin P,: The management of pleural effusions and chylothorax in lymphoma. Radiology 1965; 85: 1085-1092.
30. Boutin C, Rey F, Viallat JR,: Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995; 108: 754-758.
31. Neragi-Miandoab S,: Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 2006; 54: 1-9.
32. Groth G, Gatzemeier U, Haussingen K, et al.: Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol 1991; 2: 213-215.
33. Prakash UB, Reiman HM,: Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: Analysis of 414 cases. Mayo Clin Proc 1985; 60: 158-164. (Pubitemid 15139121)
34. Loddenkemper R,: Thoracoscopy-State of the art. Eur Respir J 1998; 11: 213-221.
35. Gordon CE, Feller-Kopman D, Balk EM, et al.: Pneumothorax following thoracentesis: A systematic review and meta-analysis. Arch Intern Med 2010; 170: 332-339.
36. Feller-Kopman D, Berkowitz D, Boiselle P, et al.: Large-volume thoracentesis and the risk of reexpansion pulmonary edema. Ann Thorac Surg 2007; 84: 1656-1661. (Pubitemid 47588147)
37. Jones PW, Moyers JP, Rogers JT, et al.: Ultrasound-guided thoracentesis: Is it a safer method? Chest 2003; 123: 418-423. (Pubitemid 36269424)
38. Putnam JB, Jr. , Light RW, Rodriguez RM, et al.: A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999; 86: 1992-1999.
39. Tremblay A, Michaud G,: Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006; 129: 362-368. (Pubitemid 43289856)
40. Patz EF, Jr. , McAdams HP, Erasmus JJ, et al.: Sclerotherapy for malignant pleural effusions: A prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 1998; 113: 1305-1311. (Pubitemid 28223821)
41. Patz EF, Jr. , McAdams HP, Goodman PC, et al.: Ambulatory sclerotherapy for malignant pleural effusions. Radiology 1996; 199: 133-135. (Pubitemid 26095827)
42. Hausheer FH, Yarbro JW,: Diagnosis and treatment of malignant pleural effusion. Cancer Metastasis Rev 1987; 6: 23-40.
43. Musani AI, Haas AR, Seijo L, et al.: Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration 2004; 71: 559-566. (Pubitemid 40091427)
44. Hewitt JB, Janssen WR,: A management strategy for malignancy-induced pleural effusion: Long-term thoracostomy drainage. Oncol Nurs Forum 1987; 14: 17-22.
45. Pien GW, Gant MJ, Washam CL, et al.: Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 2001; 119: 1641-1646. (Pubitemid 32744916)
46. Tremblay A, Mason C, Michaud G,: Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J 2007; 30: 759-762. (Pubitemid 351194838)
47. Pollak JS,: Malignant pleural effusions: Treatment with tunneled long-term drainage catheters. Curr Opin Pulm Med 2002; 8: 302-307. (Pubitemid 34625964)
48. Tan C, Sedrakyan A, Browne J, et al.: The evidence on the effectiveness of management for malignant pleural effusion: A systematic review. Eur J Cardiothorac Surg 2006; 29: 829-838.
49. Casal RF, Eapen GA, Morice RC, et al.: Medical thoracoscopy. Curr Opin Pulm Med 2009; 15: 313-320.
50. Pompeo E, Mineo TC,: Awake operative videothoracoscopic pulmonary resections. Thorac Surg Clin 2008; 18: 311-320.
51. Ferrer J, Roldan J, Teixidor J, et al.: Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest 2005; 127: 1017-1022. (Pubitemid 40775535)
52. Downey RJ, McCormack P, LoCicero J III:, Dissemination of malignant tumors after video-assisted thoracic surgery: A report of twenty-one cases. The Video-Assisted Thoracic Surgery Study Group. J Thorac Cardiovasc Surg 1996; 111: 954-960. (Pubitemid 26146048)
53. Marrazzo A, Noto A, Casa L, et al.: Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: The importance of an early intervention. J Pain Symptom Manage 2005; 30: 75-79. (Pubitemid 41021682)
54. Wolf AS, Daniel J, Sugarbaker DJ,: Surgical techniques for multimodality treatment of malignant pleural mesothelioma: Extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg 2009; 21: 132-148.
55. Flores RM,: Surgical options in malignant pleural mesothelioma: Extrapleural pneumonectomy or pleurectomy/decortication. Semin Thorac Cardiovasc Surg 2009; 21: 149-153.
56. Baldini EH, Recht A, Strauss GM, et al.: Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1997; 63: 334-338. (Pubitemid 27084548)
57. Crnjac A, Sok M, Kamenik M,: Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma. Eur J Cardiothorac Surg 2004; 26: 432-436. (Pubitemid 39024672)
58. Crnjac A,: The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions. Wien Klin Wochenschr 2004; 116: 28-32. (Pubitemid 38979925)
59. Rodriguez-Panadero F,: Talc pleurodesis for treating malignant pleural effusions. Chest 1995; 108: 1178-1179.
60. Aelony Y, King RR, Boutin C,: Thoracoscopic talc poudrage in malignant pleural effusions: Effective pleurodesis despite low pleural pH. Chest 1998; 113: 1007-1012. (Pubitemid 28216446)
61. Martini N, Bains MS, Beattie EJ, Jr. :, Indications for pleurectomy in malignant effusion. Cancer 1975; 35: 734-738.
62. LoCicero J III:, Thoracoscopic management of malignant pleural effusion. Ann Thorac Surg 1993; 56: 641-643.
63. Menzies R, Charbonneau M,: Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 1991; 114: 271-276.
64. Boutin C, Astoul P,: Diagnostic thoracoscopy. Clin Chest Med 1998; 19: 295-309. (Pubitemid 28277878)
65. Bernard A, de Dompsure RB, Hagry O, et al.: Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg 2002; 74: 213-217. (Pubitemid 34734673)
66. Fry WA, Khandekar JD,: Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol 1995; 2: 160-164.
67. Lee KA, Harvey JC, Reich H, et al.: Management of malignant pleural effusions with pleuroperitoneal shunting. J Am Coll Surg 1994; 178: 586-588. (Pubitemid 24172566)
68. Little AG, Kadowaki MH, Ferguson MK, et al.: Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg 1988; 208: 443-450. (Pubitemid 18266460)
69. Petrou M, Kaplan D, Goldstraw P,: Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting. Cancer 1995; 75: 801-805.
70. Reich H, Beattie EJ, Harvey JC,: Pleuroperitoneal shunt for malignant pleural effusions: A one-year experience. Semin Surg Oncol 1993; 9: 160-162. (Pubitemid 23095828)
71. Ukale V, Bone D, Hillerdal G, et al.: The impact of pleurodesis in malignant effusion on respiratory function. Respir Med 1999; 93: 898-902. (Pubitemid 30042641)
72. Boland GW, Gazelle GS, Girard MJ, et al.: Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions. AJR Am J Roentgenol 1998; 170: 943-946. (Pubitemid 28172878)
73. Barbetakis N, Antoniadis T, Tsilikas C,: Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer. World J Surg Oncol 2004; 2: 16.
74. Hartman DL, Gaither JM, Kesler KA, et al.: Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 1993; 105: 743-747; discussion 747-748.
75. Pearson FG, MacGregor DC,: Talc poudrage for malignant pleural effusion. J Thorac Cardiovasc Surg 1966; 51: 732-738.
76. Kennedy L, Sahn SA,: Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106: 1215-1222. (Pubitemid 24309565)
77. Shaw P, Agarwal R,: Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004; CD002916.
78. Rehse DH, Aye RW, Florence MG,: Respiratory failure following talc pleurodesis. Am J Surg 1999; 177: 437-440. (Pubitemid 29252818)
79. Ferrer J, Villarino MA, Tura JM, et al.: Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 2001; 119: 1901-1905. (Pubitemid 32744951)
80. Janssen JP, Collier G, Astoul P, et al.: Safety of pleurodesis with talc poudrage in malignant pleural effusion: A prospective cohort study. Lancet 2007; 369: 1535-1539. (Pubitemid 46670303)
81. Dresler CM, Olak J, Herndon JE II, et al.: Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005; 127: 909-915. (Pubitemid 40775523)
82. Cunningham TJ, Olson KB, Horton J, et al.: A clinical trial of intravenous and intracavitary bleomycin. Cancer 1972; 29: 1413-1419.
83. Ruckdeschel JC, Moores D, Lee JY, et al.: Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest 1991; 100: 1528-1535.
84. Sartori S, Tassinari D, Ceccotti P, et al.: Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions. J Clin Oncol 2004; 22: 1228-1233. (Pubitemid 41079836)
85. Alberts DS, Chen HS, Mayersohn M, et al.: Bleomycin pharmacokinetics in man. II. Intracavitary administration. Cancer Chemother Pharmacol 1979; 2: 127-132. (Pubitemid 9221324)
86. Heffner JE, Unruh LC,: Tetracycline pleurodesis. Adios, farewell, adieu. Chest 1992; 101: 5-7.
87. Sahn SA,: Pleural diagnostic techniques. Curr Opin Pulm Med 1995; 1: 324-330.
88. Gebbia N, Mannino R, Di Dino A, et al.: Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients. Anticancer Res 1994; 14: 739-745. (Pubitemid 24172202)
89. Heffner JE, Standerfer RJ, Torstveit J, et al.: Clinical efficacy of doxycycline for pleurodesis. Chest 1994; 105: 1743-1747. (Pubitemid 24180662)
90. Mansson T,: Treatment of malignant pleural effusion with doxycycline. Scand J Infect Dis Suppl 1988; 53: 29-34.
91. Anderson CB, Philpott GW, Ferguson TB,: The treatment of malignant pleural effusions. Cancer 1974; 33: 916-922.
92. Kennedy L, Rusch VW, Strange C, et al.: Pleurodesis using talc slurry. Chest 1994; 106: 342-346. (Pubitemid 24252022)
93. Sorensen PG, Svendsen TL, Enk B,: Treatment of malignant pleural effusion with drainage, with and without instillation of talc. Eur J Respir Dis 1984; 65: 131-135. (Pubitemid 14188709)
94. Genc O, Petrou M, Ladas G, et al.: The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg 2000; 18: 143-146. (Pubitemid 30488809)
95. Ferrer J, Montes JF, Villarino MA, et al.: Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002; 122: 1018-1027.
96. Paschoalini Mda S, Vargas FS, Marchi E, et al.: Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest 2005; 128: 684-689. (Pubitemid 41140496)
97. Chella A, Ribechini A, Dini P, et al.: [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis]. Minerva Chir 1994; 49: 1077-1082.
98. Cheng D, Chan YM, Ng TY, et al.: Mitomycin chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to gynecological cancer. Acta Obstet Gynecol Scand 1999; 78: 443-446. (Pubitemid 29199683)
99. Villanueva AG, Gray AW, Jr. , Shahian DM, et al.: Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994; 49: 23-25. (Pubitemid 24118890)
100. Sherman S, Grady KJ, Seidman JC,: Clinical experience with tetracycline pleurodesis of malignant pleural effusions. South Med J 1987; 80: 716-719. (Pubitemid 18010704)
101. Pulsiripunya C, Youngchaiyud P, Pushpakom R, et al.: The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: A prospective study. Respirology 1996; 1: 69-72. (Pubitemid 126733760)
102. Tanaka N, Takazawa K, Fujita M, et al.: Adult case of isolated noncompaction of left ventricular myocardium revealed at hospitalization for tuberculous pleuritis. J Cardiol 1999; 33: 169-174. (Pubitemid 29173854)
103. Rosso R, Rimoldi R, Salvati F, et al.: Intrapleural natural beta interferon in the treatment of malignant pleural effusions. Oncology 1988; 45: 253-256.
104. Lissoni P, Mandala M, Curigliano G, et al.: Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2. Oncology 2001; 60: 308-312. (Pubitemid 32623444)
105. Senyigit A, Bayram H, Babayigit C, et al.: Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: A review of 117 cases. Respiration 2000; 67: 623-629. (Pubitemid 32008888)